Invacare Co. (NYSE:IVC) – Research analysts at KeyCorp dropped their FY2017 earnings estimates for Invacare in a research report issued on Wednesday. KeyCorp analyst M. Mishan now expects that the health services provider will post earnings per share of ($1.96) for the year, down from their previous estimate of ($1.93). KeyCorp currently has a “Buy” rating and a $20.00 target price on the stock.

Several other equities analysts have also issued reports on IVC. Zacks Investment Research raised shares of Invacare from a “sell” rating to a “hold” rating in a report on Wednesday, October 11th. ValuEngine raised shares of Invacare from a “sell” rating to a “hold” rating in a report on Sunday, December 31st. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $16.00.

Invacare (NYSE IVC) opened at $17.60 on Monday. The company has a quick ratio of 1.57, a current ratio of 2.28 and a debt-to-equity ratio of 0.55. Invacare has a 1-year low of $9.90 and a 1-year high of $17.95. The stock has a market cap of $578.52, a price-to-earnings ratio of -7.52 and a beta of 2.45.

Invacare (NYSE:IVC) last released its quarterly earnings results on Tuesday, November 7th. The health services provider reported ($0.41) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.43) by $0.02. Invacare had a negative net margin of 7.95% and a negative return on equity of 13.33%. The business had revenue of $250.91 million for the quarter, compared to analyst estimates of $239.88 million. During the same period in the previous year, the company earned ($0.37) earnings per share. The business’s revenue for the quarter was down 6.4% on a year-over-year basis.

The company also recently declared a quarterly dividend, which was paid on Tuesday, January 16th. Shareholders of record on Thursday, January 4th were issued a $0.0125 dividend. This represents a $0.05 annualized dividend and a yield of 0.28%. The ex-dividend date was Wednesday, January 3rd. Invacare’s dividend payout ratio is currently -2.14%.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in IVC. Vanguard Group Inc. grew its holdings in shares of Invacare by 3.8% during the second quarter. Vanguard Group Inc. now owns 2,934,593 shares of the health services provider’s stock valued at $38,736,000 after buying an additional 107,359 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC grew its holdings in shares of Invacare by 654.1% during the third quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 2,383,222 shares of the health services provider’s stock valued at $37,535,000 after buying an additional 2,067,186 shares during the last quarter. Royce & Associates LP grew its holdings in shares of Invacare by 4.4% during the third quarter. Royce & Associates LP now owns 1,414,169 shares of the health services provider’s stock valued at $22,273,000 after buying an additional 59,430 shares during the last quarter. Northpointe Capital LLC grew its holdings in shares of Invacare by 96.8% during the third quarter. Northpointe Capital LLC now owns 1,151,700 shares of the health services provider’s stock valued at $18,139,000 after buying an additional 566,574 shares during the last quarter. Finally, Elk Creek Partners LLC grew its holdings in shares of Invacare by 17.5% during the third quarter. Elk Creek Partners LLC now owns 869,081 shares of the health services provider’s stock valued at $13,688,000 after buying an additional 129,676 shares during the last quarter.

ILLEGAL ACTIVITY NOTICE: “FY2017 EPS Estimates for Invacare Co. (IVC) Lowered by KeyCorp” was originally published by Watch List News and is the property of of Watch List News. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at https://www.watchlistnews.com/fy2017-eps-estimates-for-invacare-co-ivc-lowered-by-keycorp/1820942.html.

Invacare Company Profile

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.

Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.